1. 1504 Impact of worsening in patient reported symptomatic adverse events (AEs) on deterioration of daily assessed quality of life(QOL) in cancer patients receiving initial chemotherapy; prospective exploratory study. (September 2015) Authors: Horie, Y.; Mori, K.; Kyomori, C.; Izawa, N.; Taniyama, T.; Hirakawa, M.; Ogura, T.; Tsuda, T.; Nakajima, T.; Boku, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2125 Evaluation timing and cutoff value of tumor size (TS) ratio by using tumor growth inhibition (TGI) model to predict overall survival (OS) in metastatic colorectal cancer (mCRC) patients received first-line chemotherapy (CTx). (September 2015) Authors: Kito, Y.; Sakamaki, K.; Yamazaki, K.; Izawa, N.; Tsuda, T.; Morita, S.; Boku, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1058 The New Joint Weighted Scoring System Which Predicts The Modified Health Assessment Questionnaires Scores in Rheumatoid Arthritis Patients: A Validation Study Using The National Database of Rheumatic Diseases by iR-net in Japan. (15th July 2016) Authors: Ono, K.; Ohashi, S.; Oka, H.; Kadono, Y.; Omata, Y.; Matsumoto, T.; Izawa, N.; Nishino, J.; Tanaka, S.; Tohma, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗